Form 4: Pediatrix Executive Receives Equity Awards

David Haddock, EVP, GC & Corp Sec of Pediatrix Medical Group, Inc., was granted restricted shares and performance share units.

Summary

• David Haddock, Executive Vice President, General Counsel, and Corporate Secretary of Pediatrix Medical Group, Inc., received equity awards on June 22, 2026.
• The awards include 20,036 restricted shares and 51,000 Performance Share Units (PSUs).
• The restricted shares vest in installments between June 1, 2027, and June 1, 2029.
• The PSUs are contingent on both service and stock price performance hurdles, with vesting occurring on the three-year anniversary of the grant date.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting standard executive compensation practices rather than significant company performance changes.

Positives

• Grant of restricted shares and performance share units indicates management's continued investment and alignment with company performance.
• The equity awards are structured with vesting schedules tied to both service and performance, incentivizing long-term commitment and achievement of stock price targets.

Risks

• The vesting of PSUs is contingent on the company achieving specific stock price hurdles (115%, 125%, and 135% of $22.66) for at least 20 consecutive trading days, which may not be met.
• The restricted shares vest over a period of up to three years, meaning the executive's full benefit is deferred.

Future Outlook

The future outlook for the executive's compensation is tied to the company's stock performance and continued service, with specific vesting milestones to be met over the next three years.

Industry Context

StockSavvy.ai notes that the granting of equity awards, including restricted stock and performance-based units, is a common practice in the healthcare services industry to attract, retain, and incentivize key executives by aligning their interests with shareholders.

Stakeholder Impact

• Shareholders: The equity awards align executive interests with shareholder value creation, potentially leading to increased focus on stock price performance.
• Employees: Standard practice for executive compensation, may indirectly influence overall company culture and incentive structures.
• Management: Direct benefit contingent on company performance and continued service.

Next Steps

• Vesting of restricted shares on June 1, 2027, June 1, 2028, and June 1, 2029, subject to service conditions.
• Vesting of PSUs upon satisfaction of service-based and performance-based stock price hurdles, occurring on the three-year anniversary of the grant date.

Key Dates

Keywords

Pediatrix Medical Group, Form 4, Equity Awards, Restricted Stock, Performance Share Units, David Haddock, Executive Compensation, SEC Filing